Filter
2915
Filtered Results: 2915
Text search:
Access
to
Medicine
Foundation
Featured
Recommendations
258
New Publications
721
Language
Document type
No document type
1593
Studies & Reports
585
Guidelines
326
Manuals
184
Strategic & Response Plan
113
Training Material
44
Fact sheets
28
Situation Updates
20
Resource Platforms
10
Brochures
4
Infographics
4
Online Courses
3
App
1
Countries / Regions
Global
135
India
90
Kenya
87
South Africa
59
Nigeria
54
Ethiopia
53
Western and Central Europe
50
Uganda
49
Liberia
46
Nepal
45
Africa
45
Tanzania
45
Malawi
44
Bangladesh
42
Myanmar / Burma
41
Ukraine
38
Latin America and the Carribbean
38
Sierra Leone
37
Ghana
33
Rwanda
32
Zambia
32
Syria
25
Philippines
23
South–East Asia Region
22
Eastern Europe
21
Asia
20
Mozambique
18
Zimbabwe
17
East and Southern Africa
16
South Sudan
16
Lesotho
15
Namibia
15
Guinea
14
Brazil
14
West and Central Africa
13
Cameroon
12
Senegal
12
Congo, Democratic Republic of
12
Haiti
11
Cambodia
11
Middle East and North Africa
11
Indonesia
11
Yemen
10
Venezuela
9
Moldova
9
Russia
9
Tajikistan
8
Pakistan
8
Colombia
7
Thailand
7
Benin
6
Burkina Faso
6
Afghanistan
6
USA
6
Germany
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
Georgia
6
Botswana
6
Somalia
6
China
5
Laos
5
Peru
5
Lebanon
5
Vietnam
5
Sri Lanka
5
Sudan
5
Eswatini/ Swaziland
5
Albania
4
Southern Africa
4
Mali
4
North Macedonia
3
Mexico
3
Chile
3
Kyrgyzstan
3
Jordan
3
Paraguay
3
North America
3
United Kingdom
3
Bolivia
3
Poland
3
Gambia
2
Kazakhstan
2
Estonia
2
Niger
2
Hungary
2
Lithuania
2
Saudi Arabia
2
Jamaica
2
Japan
2
Bosnia and Herzegovina
2
Argentina
2
Papua New Guinea
2
Romania
2
Palestine
2
Ecuador
2
Madagascar
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Turkey
1
Iran
1
Canada
1
Congo-Brazzaville
1
Malaysia
1
Morocco
1
Qatar
1
Bulgaria
1
Italy
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Slovakia
1
Central African Republic
1
Chad
1
Bhutan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
906
Clinical Guidelines
259
Public Health
228
Women & Child Health
162
Key Resources
97
Capacity Building
55
Pharmacy & Technologies
36
Annual Report MEDBOX
1
Toolboxes
HIV
301
Mental Health
274
TB
193
COVID-19
172
Disability
116
Caregiver
111
Planetary Health
108
AMR
101
NTDs
82
Global Health Education
71
NCDs
70
Conflict
66
Pharmacy
57
Rapid Response
51
Health Financing Toolbox
47
Ebola
46
Refugee
45
Natural Hazards
20
Social Ethics
14
Zika
10
Polio
6
Specific Hazards
4
Cholera
4
Health Financing
1
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
Millions of people today cannot access medicine when they need to. This can be due to price, empty pharmacy shelves or other factors. Find out more about the situation and how the Index stimulates pharmaceutical companies to help turn it around.
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have access to treatme...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally....
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
